https://www.selleckchem.com/products/ad-5584.html
009) in estrogen-receptor positive (ER+) patients with cancer. The results suggested that plasma anti-PRA IgG levels may be a useful prognostic marker for monitoring PPVs, particularly for ER+ patients with mrBC (trial registration no. from the UMIN Clinical Trials Registry, UMIN000001844). To investigate the long-term survival of patients with primary Sjögren's syndrome (pSS) in China. Patients with pSS who fulfilled the 2002 American-European Consensus Group classification criteria were prospectively enrolled from 2004 to 2011. Their
Synes godt om
Kommentar
Del
